231 related articles for article (PubMed ID: 29353208)
21. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats.
Mehrzadi S; Fatemi I; Esmaeilizadeh M; Ghaznavi H; Kalantar H; Goudarzi M
Biomed Pharmacother; 2018 Jan; 97():233-239. PubMed ID: 29091871
[TBL] [Abstract][Full Text] [Related]
22. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
23. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
[TBL] [Abstract][Full Text] [Related]
24. Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
Cui WX; Yang J; Chen XQ; Mao Q; Wei XL; Wen XD; Wang Q
Am J Chin Med; 2013; 41(3):487-502. PubMed ID: 23711137
[TBL] [Abstract][Full Text] [Related]
25. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM
Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422
[TBL] [Abstract][Full Text] [Related]
26. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
[TBL] [Abstract][Full Text] [Related]
27. Preparation and Evaluation of Functional Foods for Prevention of Non-alcoholic Fatty Liver Disease.
A Mohamed D; S Abdelgayed S; A Essa H; S Mohamed R
Pak J Biol Sci; 2018 Jan; 21(9):454-462. PubMed ID: 30724047
[TBL] [Abstract][Full Text] [Related]
28. Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.
Xu T; Zhou J; Zhu J; Zhang S; Zhang N; Zhao Y; Ding C; Shi X; Yao J
Metab Brain Dis; 2017 Apr; 32(2):483-491. PubMed ID: 27957651
[TBL] [Abstract][Full Text] [Related]
29. Preventive effect of curcumin on inflammation, oxidative stress and insulin resistance in high-fat fed obese rats.
Maithilikarpagaselvi N; Sridhar MG; Swaminathan RP; Sripradha R
J Complement Integr Med; 2016 Jun; 13(2):137-43. PubMed ID: 26845728
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
Yamada H; Ohashi K; Suzuki K; Munetsuna E; Ando Y; Yamazaki M; Ishikawa H; Ichino N; Teradaira R; Hashimoto S
Clin Chim Acta; 2015 Jun; 446():267-71. PubMed ID: 25958847
[TBL] [Abstract][Full Text] [Related]
31. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.
Kim J; Lee H; Lim J; Oh J; Shin SS; Yoon M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420164
[TBL] [Abstract][Full Text] [Related]
32. Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease.
Chang X; Wang Z; Zhang J; Yan H; Bian H; Xia M; Lin H; Jiang J; Gao X
J Transl Med; 2016 Sep; 14():266. PubMed ID: 27629750
[TBL] [Abstract][Full Text] [Related]
33. Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes.
Zabihi NA; Pirro M; Johnston TP; Sahebkar A
Curr Pharm Des; 2017; 23(7):969-982. PubMed ID: 27748192
[TBL] [Abstract][Full Text] [Related]
34. [Emodin worsens methionine-choline-deficient diet-induced non-alcoholic fatty liver disease in mice].
Liu Q; Yu F; Yu N; Shi M; Wang F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):620-4. PubMed ID: 25940288
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo.
Chen L; Liu T; Wang Q; Liu J
BMC Complement Altern Med; 2017 Apr; 17(1):233. PubMed ID: 28449676
[TBL] [Abstract][Full Text] [Related]
36. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
37. Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation.
Noori M; Jafari B; Hekmatdoost A
J Sci Food Agric; 2017 Jun; 97(8):2327-2332. PubMed ID: 27717115
[TBL] [Abstract][Full Text] [Related]
38. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
39. Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease.
Jiang G; Chen D; Li W; Liu C; Liu J; Guo Y
Pharm Biol; 2020 Dec; 58(1):1177-1183. PubMed ID: 33253604
[TBL] [Abstract][Full Text] [Related]
40. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
